Equibles does not estimate personal net worth.
Get an email with a short summary when Boston Scientific Corp publishes a filing, an earnings call transcript or a press release.
Get BSX alertsJohn Monson is recorded as CFO at Boston Scientific Corp (BSX). John Monson has spoken on 4 earnings calls across 1 company, most recently for Boston Scientific Corp on October 28, 2026. Boston Scientific Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Boston Scientific Corp includes Michael Mahoney (CEO), Jonathan Monson (CFO), Joe Fitzgerald (COO) and 7 others.
“Before I provide details on our third quarter financial performance, I want to express my gratitude to our customers, physicians, and employees for their patience and partnership as we work through the recent cyber incident.”
“Second quarter consolidated revenue of $5,442,000,000 represents 7.5% reported growth versus second quarter 2025 and includes a 50 basis point tailwind from foreign exchange, which was in line with our expectations.”
“First quarter consolidated revenue of $5,203,000,000 represents 11.6% reported growth versus first quarter 2025 and includes a 220 basis point tailwind from foreign exchange which was in line with our expectations.”
“Fourth quarter, consolidated revenue of $5,286,000,000 represents 15.9% reported growth versus fourth quarter 2024 and includes a 160 basis point tailwind from foreign exchange, which was in line with our expectations.”
Medical Devices · Healthcare
CFO
